MAFLD Clinical Trials

4 recruiting

MAFLD Trials at a Glance

8 actively recruiting trials for mafld are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Hangzhou, Beijing, and Dhaka. Lead sponsors running mafld studies include Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Innovent Biologics (Suzhou) Co. Ltd., and Assiut University.

Browse mafld trials by phase

Treatments under study

About MAFLD Clinical Trials

Looking for clinical trials for MAFLD? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new MAFLD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about MAFLD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Incidence of Liver Disease-Related Outcomes in People With HIV

Liver FibrosisHIVHepatic Steatosis+3 more
Shanghai Public Health Clinical Center320 enrolled2 locationsNCT06940375
Recruiting

Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

MAFLDMetabolic Abnormalities
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1,000 enrolled1 locationNCT07470749
Recruiting
Not Applicable

A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD

MAFLD
The Affiliated Hospital of Hangzhou Normal University2,000 enrolled1 locationNCT07233486
Recruiting

VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients

MAFLDHepatic DisordersIntestinal Failure-associated Liver Disease+2 more
Sahlgrenska University Hospital550 enrolled1 locationNCT07202910
Recruiting
Not Applicable

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Fatty Liver DiseaseHepatomegalyFatty Liver+5 more
Phenomen Pharma90 enrolled1 locationNCT07068191
Recruiting
Phase 3

A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

OverweightMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent Biologics (Suzhou) Co. Ltd.470 enrolled1 locationNCT06884293
Recruiting
Phase 2

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Metabolic-associated Fatty Liver Disease (MAFLD)
Li Lab,MD100 enrolled2 locationsNCT06798948
Recruiting

The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD

Detect the Significance of Remnant Cholesterol in Detection Severity of MAFLD
Assiut University60 enrolled1 locationNCT06449092